Medical Breakthroughs
AI Health: $167M Fines Reshape Investment & Regulatory De-risking
The year 2026 has marked a critical inflection point for the burgeoning AI in healthcare sector,…
Medical Breakthroughs
Medical Breakthroughs
FDA AI/ML Guidance: Investor Impact on Cardiac AI SaMD
The regulatory landscape for artificial intelligence and machine learning (AI/ML) in healthcare is in constant flux,…
Medical Breakthroughs
FDA’s AI Crackdown: What Investors Need to Know Now
The landscape of healthcare AI investment is fundamentally shifting. No longer is innovation alone sufficient; regulatory…
Medical Breakthroughs
AMA’s AI Legislation: Your Cardiac AI Investment De-Risking Guide
The American Medical Association’s (AMA) recent push for formal AI oversight legislation in healthcare marks a…
Medical Breakthroughs
Healthcare AI ROI: Beyond Vendor Claims to Verified Value
The landscape of digital health is awash with bold claims of return on investment (ROI). Every…
Medical Breakthroughs
AI Health Regulation: Top 10 Investor Insights This Quarter
The intricate dance between innovation and regulation in healthcare AI is a constant source of both…
Medical Breakthroughs
Bakul Patel: De-Risking AI Health for Investors
The article accurately reflects Bakul Patel’s past role and enduring influence on FDA digital health regulation.…
Medical Breakthroughs
AI Device Recalls: Unpacking Post-Market Surveillance Gaps
The rapid proliferation of artificial intelligence in healthcare promises transformative advancements, yet recent data on FDA…
Medical Breakthroughs
UnitedHealth AI Lawsuit: Redefining HealthTech’s Regulatory Future
The recent class action lawsuit against UnitedHealth Group (UHG) for alleged algorithmic coverage denials has sent…
Medical Breakthroughs
Triple Aim at 18: Defining Good Healthcare AI for Investors
The article appears to be accurate and up-to-date as of July 16, 2026. The statement “Eighteen…